首页
订购/客服:400-666-5481

Tat-NR2Baa

    
≥90%

源叶(MedMol)
V48581 一键复制产品信息
847829-41-8
C103H184N42O29
2474.87
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys-Leu-Ser-Ser-Ile-Glu-Ala-Asp-Ala;YGRKKRRQRRRKLSSIEADA
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
V48581-1mg
≥90%

¥2200.00

货期:3-5天 - - - -
V48581-5mg
≥90%

¥5500.00

货期:3-5天 - - - -
V48581-10mg
≥90%

¥8770.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: Tat-NR2BAA is the control peptide of Tat-NR2B9c , inactive. The sequence of Tat-NR2BAA is similar to Tat-NR2B9c, but it has a double-point mutation in the COOH terminal tSXV motif, making it incapable of binding PSD-95. Tat-NR2B9c is a membrane-permeant peptide and disrupts PSD-95/NMDAR binding, correlate with uncoupling NR2B- and/or NR2A-type NMDARs from PSD-95.
体外研究: Tat-NR2BAA (125 ng; 20 mins) does not effects interactions between PSD-95 and NR2B subunits. In contrast, coimmunoprecipitation of PSD-95 with NR2B subunits is markedly decreased in rats pretreated with the disrupting peptide Tat-NR2B9c in lumbar dorsal horn tissue.
Tat-NR2Baa (125 ng or 1.25 μg; 20 minutes before collection of lumbar dorsal horn tissue) is the control group of Tat-NR2B9c. Tat-NR2B9c produces a significant and robust reduction of postdischarge, indicating the hyperexcitability of the cell. But Tat-NR2Baa has no effects, even at a dose 100× greater than the active peptide Tat-NR2B9c .
Tat-NR2Baa (1 μM; pre-treatment 1 hour) is the control group in the Co-IP assay. Tat-NR2B9c (1 μM) disrupts NR2B/PSD95 interaction, and the coupling of NR2B to PSD-95 is more sensitive than NR2A/PSD95 to disruption in hippocampal neurons.
保存条件: -20°C, 干燥
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 0.404 ml 2.02 ml 4.041 ml
5 mM 0.081 ml 0.404 ml 0.808 ml
10 mM 0.04 ml 0.202 ml 0.404 ml
50 mM 0.008 ml 0.04 ml 0.081 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×